Ads
related to: simparica rebate zoetis- Get Dosage Reminders
Enroll Today & Receive Reminders
Don't Miss Your Pet's Next Dose!
- Get Zoetis Petcare Tips
Our Blog is Your go to Resource for
Everything Petcare.
- Get Dosage Reminders
Search results
Results from the WOW.Com Content Network
Zoetis (NYSE: ZTS) Q4 2024 Earnings Call Feb 13, 2025, 8:30 a.m ... the global triple combination market pioneered and led by Simparica Trio in the U.S. is projected to more than double to $4.5 ...
Zoetis (NYSE: ZTS) Q3 2024 Earnings Call Nov 04, 2024, 8:30 a.m. ET. Contents: Prepared Remarks. Questions and Answers. ... Simparica Trio posted U.S. growth of 29% with $237 million in revenue ...
Zoetis (NYSE: ZTS) Q2 2024 Earnings Call Aug 06, 2024, 8:00 a.m. ET. Contents: Prepared Remarks. ... Simparica Trio posted U.S. growth of 19% in the quarter on $254 million in revenue. We are ...
Sarolaner, sold under the brand name Simparica, is an ectoparasiticide veterinary medication for the treatment of flea and tick infestations in dogs. [7] [8] It is also used off-label to control sarcoptic mange and demodectic mange. [8] Sarolaner is also a component of the combination drug Simparica Trio, which contains sarolaner, moxidectin ...
The Medicaid Drug Rebate Program is a program in the United States that was created by the Omnibus Budget Reconciliation Act of 1990 (OBRA'90). The program establishes mandatory rebates that drug manufacturers must pay state Medicaid agencies related to the dispensing of outpatient prescription drugs covered by Medicaid .
Zoetis Inc. (/zō-EH-tis/ [4]) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. [ 5 ] [ 4 ] [ 6 ] The company was a subsidiary of Pfizer , [ 7 ] the world's largest drug maker , but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company.
Ads
related to: simparica rebate zoetis